![](https://www.lifesciencehistory.com/wp-content/uploads/2024/05/coronavirus_covid19_cdc_banner.jpg)
Vaxart announced initiation of Coronavirus vaccine program
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based on its proprietary oral vaccine platform, VAAST.
Vaxart planned to generate vaccine candidates based on the published genome of the 2019 Novel Coronavirus (2019-nCoV) and evaluate them in preclinical models for their ability to generate both mucosal and systemic immune responses.
Tags:
Source: Vaxart
Credit:
![](https://www.lifesciencehistory.com/wp-content/uploads/2024/11/lsh_job_ad_banner_horizontal_2025.png)